Compare AFLAC Incorporated (AFL) vs Nu Holdings Ltd (NU) Price & Performance

Aflac (AFL) trades at $121.49, up 0.5% with a bullish technical signal supported by moving averages. The stock shows strong fundamentals with a 25.32% net income margin and 16.47% ROE, though recent Q1 2026 earnings missed expectations. Analyst consensus is mixed with 28% buy ratings and a $113.57 price target below current levels. Recent developments include strong dividend performance and upcoming Q2 2026 results announcement on August 6, 2026.

The outlook remains cautiously optimistic with solid profitability and dividend stability, but faces headwinds from recent earnings misses and premium valuation pressure. Key opportunities include continued growth in Japan and U.S. markets, while risks involve medical cost inflation and uneven revenue trends. The stock's current premium to analyst targets suggests limited near-term upside potential.

NU stock trades at $13.61, showing no change in the last 24 hours. The technical outlook is bullish based on moving averages, with key support at $13 and resistance at $14. Fundamentally, the company demonstrates robust growth, with revenue increasing from $3.0B in 2022 to $10.63B in 2025 and net income turning positive to $2.87B. Recent earnings show mixed results, with a beat in Q3 2025 but misses in Q4 2025 and Q1 2026 against expectations.

The investment outlook is positive, supported by strong analyst consensus with a $14.98 price target and 55% buy ratings. Key opportunities include expansion in Latin America and a high return on equity of 30.04%. Risks involve recent earnings misses, competitive pressures, and macroeconomic volatility in emerging markets. The stock presents a growth opportunity but requires monitoring of execution and regional economic conditions.